Results 1 to 10 of about 5,794,088 (264)

A genomic-led strategy to anticipate drug safety effects. [PDF]

PLoS Genet
Ferolito BR, Horimoto ARVR, Gravel-Pucillo K, Golden DJ, Dashti H, Giambartolomei C, Rasooly D, Matty R, Gaziano L, Tsepilov Y, Costa L, Kosik N, Ioannidis H, Karim M, Winicki G, Hunter F, Langenberg C, Whittaker JC, Million Veteran Program, Cai T, Peloso GM, Zdrazil B, Ghoussaini M, Leach AR, Muralidhar S, Smit IA, Casas JP, Gaziano JM, Cho K, Pereira AC.   +29 more
europepmc   +2 more sources

Adverse Drug Reactions: Building Drug Safety Beyond Marketing Authorisation. [PDF]

J Clin Med
Belančić A, Mudnić I.
europepmc   +1 more source

Editorial: Pharmacists and patient safety: focusing on drug safety. [PDF]

Front Pharmacol
He Z, Fang W, Chen Z.
europepmc   +1 more source

Drug safety in patients with mitochondrial disease: an observational cohort study. [PDF]

Neurol Sci
Järvinen O, Martikainen MH.
europepmc   +1 more source

Similarity-based profiling of pharmacovigilance data for drug safety pattern discovery. [PDF]

Korean J Physiol Pharmacol
Park S, Wi S, Jo H, Kwon Y, Jeon N, Lee H.   +5 more
europepmc   +1 more source

Association of Guillain-Barré Syndrome With Nonavalent Human Papillomavirus Vaccine: A Postmarketing Drug Safety Study. [PDF]

Obstet Gynecol Int
González Mariño MA.
europepmc   +1 more source

Medication-Associated Xerostomia and Oral Symptom Burden in Midlife Women: A Drug Safety Perspective Across the Menopausal Transition. [PDF]

Pharmaceuticals (Basel)
Dragomir AC, Moleriu RD, Marin RC, Buzatu AR, Muntean C, Piroș T, Crintea IN, Sala-Cirtog M, Seclaman E, Dinuti M.   +9 more
europepmc   +1 more source

Analytic Misjudgment of Drug Safety Evidence and Causality: From the Prosecutor's Fallacy and Simpson's Paradox to Artificial Intelligence. [PDF]

Drug Saf
Hammad TA, Rochon J.
europepmc   +1 more source

Framework for identifying reference countries in drug safety evaluation: an application of the analytic hierarchy process. [PDF]

J Pharm Policy Pract
Choi G, Bae S.
europepmc   +1 more source

The refinement of drug safety governance based on contradiction matrix. [PDF]

BMC Public Health
Yao Y, Yang F, Zhang W.
europepmc   +1 more source